Equity
€8,000 from €60,642 in 2023
Equity fell by 87% in 2 years.
SVmédic
Lifetime
5 annual accounts with figures on one time axispeak €61,953 (2024)
€43,435▼ 29.9%
peak €40,344 (2024)
€24,791▼ 38.6%
peak €60,642 (2023)
€8,000▼ 4.1%
€71,551▼ 7.4%
Board1 name since 2021
1 director
Documentsfilings and deeds
26-06-202635 days before the deadline
2025abbreviated format
Gross margin from €61,953 to €43,435Result from €40,344 to €24,791Dividend €25,134
Key points
from the 2025 annual accountsTurnover
≈ €140,000 estimated
The accounts state no turnover.
Debts
€71,551 90% of the balance sheet
Financial debts 23%Suppliers 9%Taxes and wages 17%Other 51%
Of this, €55,165 falls due within a year.
Filings
5 annual accounts 1 late
The 2021 accounts came 24 days late. The other four were filed on time.
Starting capital
€8,000 100 shares
Position in the sector
€8,000
Less equity than 93% of companies in human health. Sector median €437,454 · 2,810 companies.
Checked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Comparable companies, two years later
In July 2024, 6,715 companies had the same profile as SVmédic has now. Each dot stands for 17 companies, two years later.
95.8%
were still trading
2.2%
stopped another way
1.8%
went bankrupt
Another 0.1% stopped without a precise date, possibly only after those two years.
Test of the method
The method was tested on the 497,762 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 6,715 companies, not a prediction for SVmédic. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0768821208
Incorporation
Founding capital of €8,000, 100 shares · Founder: (comparante,fondateur) · Appointment: (director) · published on 31-05-2021 · Gazette deed
First establishment
Heldenlaan 25/1, Auderghem
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| SVmédic Auderghem | €79,551 | €43,435 | 10.1% | - |
| KINNAERT MD Eupen | €73,533 | €43,483 | 65.2% | - |
| Elisabeth De Greef - pediatrie Hoeilaart | €80,835 | €37,595 | 3.1% | - |
| SOMERS LALOUX Forest | €100,628 | €48,075 | 3.9% | - |
| BE LIFE MEDICAL CLINIC Brussels | €58,884 | €44,283 | 35.3% | - |
| EVANES Woluwe-Saint-Pierre | €81,829 | €37,745 | 84.7% | - |
| Waterloo Heart Clinic Braine-l'Alleud | €85,875 | €50,997 | 98.4% | - |
These companies have the same main activity as SVmédic: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €58,900 and €101,000, founded between 2020 and 2022.
Official details
Source: KBO- Status
- Active since 27-05-2021Normal situation
- Activity
- Specialist medical practiceNACE 86220
- Establishment unit
- 2.317.729.7771160 Auderghem, since 27-05-2021
- Financial year end
- 31 December
- Peppol
- Reachable since 06-03-2026
Annual accounts 2025
- €79,551▼ 7.1%
- Filing
- Filed on 26-06-2026, 35 days before the end of the filing period
Insights on SVmédic
SVmédic files the abbreviated format. That format states no turnover. The gross margin rose from €31,531 in 2021 to €43,435 in 2025.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about SVmédic
- What is the company number of SVmédic?
- The company number of SVmédic is 0768.821.208. The VAT number is the same number with BE in front: BE 0768.821.208.
- Where is SVmédic based?
- The registered office is at Heldenlaan 25/1, 1160 Auderghem.Company details
- What does SVmédic do?
- According to the KBO register, the main activity is specialist medical practice (NACE 86220).
- What is the legal form of SVmédic?
- SVmédic is a private limited company (BV).
- When was SVmédic founded?
- SVmédic was founded on 27-05-2021.
- Is SVmédic still active?
- Yes, SVmédic is an active enterprise in the KBO register.
- What is the turnover of SVmédic?
- The turnover in financial year 2025 is ≈ €140,000. This figure is estimated from the gross margin of €43,435 and 63 comparable companies (NACE 86). It probably lies between €96,000 and €180,000.Financials
- Is SVmédic profitable?
- In financial year 2025, SVmédic made a profit of €24,791.
- Where can I find the annual accounts of SVmédic?
- SVmédic filed 5 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of SVmédic due?
- SVmédic must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.